Farber, Robert H.
1005  results:
Search for persons X
?
2

Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal An..:

Newfield, Ron S ; Sarafoglou, Kyriakie ; Fechner, Patricia Y...
The Journal of Clinical Endocrinology & Metabolism.  108 (2023)  11 - p. 2871-2878 , 2023
 
?
3

Pharmacokinetics of Budesonide Oral Suspension in Children ..:

Gupta, Sandeep K. ; Hill, Malcolm ; Vitanza, Joanne M....
Journal of Pediatric Gastroenterology & Nutrition.  75 (2022)  2 - p. 186-191 , 2022
 
?
4

Crinecerfont Lowers Elevated Hormone Markers in Adults With..:

Auchus, Richard J ; Sarafoglou, Kyriakie ; Fechner, Patricia Y...
The Journal of Clinical Endocrinology & Metabolism.  107 (2021)  3 - p. 801-812 , 2021
 
?
5

Clinical development of valbenazine for tics associated wit..:

Farber, Robert H. ; Angelov, Angel ; Kim, Kristine...
Expert Review of Neurotherapeutics.  21 (2021)  4 - p. 393-404 , 2021
 
?
6

Single-Dose Study of a Corticotropin-Releasing Factor Recep..:

Turcu, Adina F. ; Spencer-Segal, Joanna L. ; Farber, Robert H....
The Journal of Clinical Endocrinology & Metabolism.  101 (2016)  3 - p. 1174-1180 , 2016
 
?
8

A pharmacokinetic evaluation of five H1 antagonists after a..:

Madan, Ajay ; O'Brien, Zhihong ; Wen, Jianyun...
British Journal of Clinical Pharmacology.  67 (2009)  3 - p. 288-298 , 2009
 
?
15

Covariation of Mutations in the V3 Loop of Human Immunodefi..:

Bette T. M. Korber ; Farber, Robert M. ; Wolpert, David H..
Proceedings of the National Academy of Sciences of the United States of America.  90 (1993)  15 - p. 7176-7180 , 1993
 
1-15